{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:31:13Z","timestamp":1789997473923,"version":"4.0.1"},"reference-count":38,"publisher":"VM Media SP. zo.o VM Group SK","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.pjnns.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T02:39:41Z","timestamp":1461983981000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Bone metabolism and vitamin D status in patients with multiple sclerosis"],"prefix":"10.5603","volume":"50","author":[{"given":"Katarzyna","family":"K\u0119pczy\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Przedlacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Zakrzewska-Pniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"key":"10.1016\/j.pjnns.2016.04.010_bib0195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/187152712801661266","article-title":"Multiple sclerosis: risk factors and their interactions","volume":"11","author":"Disanto","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0200","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/WNL.0b013e318216715e","article-title":"Relationship of UV exposure to prevalence of multiple sclerosis in England","volume":"6","author":"Ramagopalan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0205","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.abb.2008.03.038","article-title":"The direct role of vitamin D on bone homeostasis","volume":"473","author":"St-Arnaud","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0215","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1352458511415562","article-title":"Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis","volume":"18","author":"Cox","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0225","first-page":"544","article-title":"The role of T cells in osteoporosis","volume":"20","author":"Zhao","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458509102844","article-title":"Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis","volume":"15","author":"Hiremath","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0235","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"Van Amerongen","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/IJGM.S22255","article-title":"Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features","volume":"4","author":"Dionyssiotis","year":"2011","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0245","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458510368985","article-title":"Osteoporosis in multiple sclerosis","volume":"16","author":"Hearn","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0250","doi-asserted-by":"crossref","first-page":"596294","DOI":"10.4061\/2011\/596294","article-title":"Bone health in patients with multiple sclerosis","volume":"2011","author":"Zikan","year":"2011","journal-title":"J Osteoporos"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0255","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the Mc Donald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0260","first-page":"589587","article-title":"Vitamin D status in Central Europe","author":"P\u0142udowski","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5603\/EP.2013.0012","article-title":"Practical guidelines for the supplementation of vitamin D and treatment of deficits in Central Europe: recommended vitamin D intakes in general population and groups at risk of vitamin D deficiency","volume":"64","author":"P\u0142udowski","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"July (2)","key":"10.1016\/j.pjnns.2016.04.010_bib0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0b013e3182242d34","article-title":"Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome","volume":"77","author":"Moen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0275","first-page":"56","article-title":"Risk factors of osteoporosis in women with multiple sclerosis","volume":"3","author":"Khachanova","year":"2006"},{"issue":"1","key":"10.1016\/j.pjnns.2016.04.010_bib0280","first-page":"19","article-title":"Factors affecting bone mineral density in multiple sclerosis patients","volume":"12","author":"Ayatollahi","year":"2013","journal-title":"Iran J Neurol"},{"issue":"3","key":"10.1016\/j.pjnns.2016.04.010_bib0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1179\/2295333715Y.0000000002","article-title":"Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis","volume":"70","author":"Coskun Benlidy","year":"2015","journal-title":"Acta Clin Belg"},{"issue":"12","key":"10.1016\/j.pjnns.2016.04.010_bib0290","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/00207454.2014.988332","article-title":"BMI levels with MS bone mineral density levels in adults with multiple sclerosis: a meta-analysis","volume":"125","author":"Huang","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0295","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-014-0173-3","article-title":"Osteoporosis and multiple sclerosis: risk factors, pathophysiology and therapeutic interventions","volume":"28","author":"Gupta","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.04.021","article-title":"Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis","volume":"570","author":"Duan","year":"2014","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.pjnns.2016.04.010_bib0305","doi-asserted-by":"crossref","first-page":"e45703","DOI":"10.1371\/journal.pone.0045703","article-title":"Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population based case control study","volume":"7","author":"Moen","year":"2012","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.pjnns.2016.04.010_bib0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","article-title":"Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity","author":"Ozgocmen","year":"2005","journal-title":"J Bone Miner Metab"},{"issue":"76","key":"10.1016\/j.pjnns.2016.04.010_bib0315","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/WNL.0b013e31821cccf5","article-title":"Vitamin D in African Americans with multiple sclerosis","author":"Gelfand","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0320","first-page":"54","article-title":"Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis","volume":"11","author":"Harandi","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0325","first-page":"585","article-title":"Vitamin D3 concentration correlates with the severity of multiple sclerosis","volume":"4","author":"Shahbeigi","year":"2013","journal-title":"Int J Prev Med"},{"issue":"2","key":"10.1016\/j.pjnns.2016.04.010_bib0330","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5114\/ninp.2013.34730","article-title":"Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study","author":"Kubicka","year":"2013","journal-title":"Neurol Neurochir Pol"},{"issue":"9","key":"10.1016\/j.pjnns.2016.04.010_bib0335","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","article-title":"Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial","volume":"258","author":"Steffensen","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0340","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/10408363.2014.901291","article-title":"Role of vitamin D in acquired immune and autoimmune diseases","volume":"51","author":"Delvin","year":"2014","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0345","first-page":"1307","article-title":"Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs","volume":"23","author":"Suzuki","year":"2013","journal-title":"Clin Calcium"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0350","doi-asserted-by":"crossref","first-page":"405","DOI":"10.33549\/physiolres.932299","article-title":"Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids","volume":"61","author":"Zikan","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0355","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/nyas.12446","article-title":"Bone safety of low-dose glucocorticoids in rheumatic diseases","volume":"1318","author":"Saag","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.pjnns.2016.04.010_bib0360","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1177\/1352458514566417","article-title":"Short-term: high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis","volume":"21","author":"Olsson","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0365","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","article-title":"Long-term effects of intravenous high dose methyloprednisolone pulses on bone mineral density in patients with multiple sclerosis","volume":"12","author":"Zorzon","year":"2005","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.pjnns.2016.04.010_bib0370","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-008-0787-8","article-title":"The incidence and risk of hip fractures in Poland","volume":"20","author":"Czerwi\u0144ski","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0375","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.418","article-title":"The risk of fractures in patients with multiple sclerosis: the UK general practice research database","volume":"26","author":"Bazelier","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pjnns.2016.04.010_bib0380","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/WNL.0b013e318259e0ff","article-title":"Risk of fractures in patients with multiple sclerosis","volume":"78","author":"Bazelier","year":"2012","journal-title":"Neurology"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384316300263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T08:12:22Z","timestamp":1600503142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384316300263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0028384316300263"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.04.010","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metabolism and vitamin D status in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2016.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}